Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
0
Trial Recruitment Size
260
Trial Sponsor
Clinical Trial Start Date
2011
0Primary Completion Date
July 7, 2017
0Study Completion Date
July 7, 2017
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Genetic0
Intervention Name
SB-728-T0
Interventional Trial Phase
Phase 20
Phase 10
Participating Facility
Official Name
A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART0
Last Updated
May 24, 2021
0Allocation Type
Non-Randomized0
Intervention Model
Sequential Assignment0
Masking Type
None (Open Label)0
Study summary
The purpose of the study is to evaluate the safety, tolerability and effect on HIV viral load, of escalating doses of cyclophosphamide administered 1 day prior to SB-728-T infusion.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
